Christopher Boerner
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2023-11-01
- Valid until
- still holds
- Published
- 2023-04-26
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-12 · its source page states the value and the date
- Confidence
- 0.95
Sources
“appointed Christopher Boerner, Ph.D., to serve as the Company’s Chief Operating Officer, effective April 26, 2023, and as the Chief Executive Officer, effective November 1, 2023.”— what the page says, read 2026-11-12
Cite this claim
Plain text
AsOf. "Bristol-Myers Squibb ceo: Christopher Boerner", as of 2023-11-01. Claim clm_3CCAF5DFD241, https://asof.is/claim/clm_3CCAF5DFD241, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/14272/000114036123020605/0001140361-23-020605-index.htm.
APA
AsOf. (2023). Bristol-Myers Squibb ceo: Christopher Boerner (as of 2023-11-01) [Record clm_3CCAF5DFD241]. Retrieved November 13, 2026, from https://asof.is/claim/clm_3CCAF5DFD241 (source: https://www.sec.gov/Archives/edgar/data/14272/000114036123020605/0001140361-23-020605-index.htm)
BibTeX
@misc{asof_clm_3CCAF5DFD241,
author = {AsOf},
title = {Bristol-Myers Squibb ceo: Christopher Boerner},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_3CCAF5DFD241}},
note = {Claim clm\_3CCAF5DFD241, as of 2023-11-01; source: https://www.sec.gov/Archives/edgar/data/14272/000114036123020605/0001140361-23-020605-index.htm},
urldate = {2026-11-13}
}On the record
/claim/clm_3CCAF5DFD241.md/v1/claims/clm_3CCAF5DFD241submit a correction